Option Care Health Inc Stock Price, News & Analysis

Option Care Health (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services in the U.S., will announce its first-quarter results for the period ending March 31, 2023, on May 4, 2023, prior to market opening.

Following this announcement, management will host a conference call at 8:30 a.m. ET to discuss the results. Interested parties can join by calling 800-445-7795 (U.S.) or 785-424-1699 (international), using conference ID “OPCH Q123.” A live audio webcast will also be available, along with a replay for on-demand listening shortly after the call.

With over 7,500 team members, including more than 4,500 clinicians, Option Care Health remains focused on enhancing patient care across all 50 states. For further details, visit OptionCareHealth.com.

Walgreens Boots Alliance (WBA) has sold approximately 15.5 million shares of Option Care Health (OPCH), raising funds at $30.75 per share. This includes 13.0 million shares in an underwritten secondary offering and a concurrent repurchase of 2.5 million shares by OPCH. Following the sale, WBA's ownership in OPCH decreased from 14% to 6%. The proceeds will primarily be allocated for debt paydown and to support WBA's strategic initiatives.

Option Care Health (NASDAQ: OPCH) announced a secondary offering of 13 million shares by an affiliate of Walgreens Boots Alliance, with no proceeds going to the company. Concurrently, Option Care plans to repurchase shares worth approximately $75 million from the selling stockholder, funded by cash on hand. The repurchase is contingent on the closing of the offering, which is underwritten by Goldman Sachs. The company emphasizes its role as the largest independent provider of home infusion services, catering to patients across 50 states.

Option Care Health (Nasdaq: OPCH) reported its financial results for Q4 and the full year 2022, showcasing a 10.8% increase in net revenue to $1,027.2 million compared to Q4 2021. Gross profit rose 8.9% to $231.1 million, representing 22.5% of revenue. However, net income fell to $47.5 million or $0.26 EPS, down from $75.5 million or $0.42 EPS a year prior. For the full year, net revenue grew 14.7% to $3,944.7 million, with net income of $150.6 million ($0.83 EPS). The company has authorized a $250 million share repurchase program and projects 2023 net revenue between $4.15 billion and $4.375 billion.

Option Care Health (NASDAQ: OPCH) will announce its Q4 and full-year results for 2022 on February 23, 2023, before the market opens. The company is the largest independent provider of home and alternate site infusion services in the U.S., employing over 7,500 team members, including 4,500 clinicians. A conference call to discuss these results is scheduled for 8:30 a.m. E.T. the same day. Participants can pre-register for the call or access it via a live audio webcast. A replay will be available shortly after the call for 90 days. For more information, visit OptionCareHealth.com.